Skip to content

Neuroplasticity: all studies

Page 146 of 178: studies 1,451 to 1,460 of 1,773, newest first. Back to the neuroplasticity overview

Research

Ready for a "breakthrough" with ketamine? A look at recent pharmacological insights!

Current Opinion in Anaesthesiology August 1, 2021 Sabine Himmelseher, Eberhard F Kochs

To update pharmacological insights on ketamine integrating information from different disciplines for developing steps to "breakthrough" approaches in clinical challenges. Pharmacokinetic/pharmacodynamic (PK/PD) models have incorporated recirculation, ketamine metabolites, drug-drug interaction, and covariates such as age. Ketamine-induced relief from treatment-resistant depression has been...

Rapid-acting antidepressants and the regulation of TrkB neurotrophic signalling-Insights from ketamine, nitrous oxide, seizures and anaesthesia.

Basic & Clinical Pharmacology & Toxicology August 1, 2021 Samuel Kohtala, Tomi Rantamäki

Increased glutamatergic neurotransmission and synaptic plasticity in the prefrontal cortex have been associated with the rapid antidepressant effects of ketamine. Activation of BDNF (brain-derived neurotrophic factor) receptor TrkB is considered a key molecular event for antidepressant-induced functional and structural synaptic plasticity. Several mechanisms have been proposed to underlie...

DOI: 10.1111/bcpt.13598 (opens in new tab) Full text (opens in new tab) Electroencephalogram Energy metabolism Protein phosphorylation Rapid-acting antidepressant +1

Unbinding the self

Philosophy of Psychedelics August 1, 2021 Chris Letheby

‘Unbinding the self’ outlines the predictive self-binding account of psychedelic therapy introduced by Letheby and Gerrans (2017). On this account, the networks targeted by psychedelics integrate or ‘bind’ information from multiple sources into a hierarchical predictive model of the self. In pathological conditions, detrimental forms of self-modelling can become rigidly entrenched. By...

The mechanisms of psychedelic therapy

Philosophy of Psychedelics August 1, 2021 Chris Letheby 2 citations

‘The mechanisms of psychedelic therapy’ presents arguments against three theories of psychedelic therapy. The Molecular Neuroplasticity Theory ascribes therapeutic benefits to an experience-independent molecular mechanism. This theory is undermined by the correlation between ‘mystical-type experiences’ and beneficial outcomes, which suggests that genuinely psychological mechanisms are involved....

Novel Class of Psychedelic Iboga Alkaloids Disrupts Opioid Use

bioRxiv (Cold Spring Harbor Laboratory) July 23, 2021 Václav Havel, Andrew C Kruegel, Benjamin Bechand et al. 3 citations preprint

Abstract Substance use and related mental health epidemics are causing increasing suffering and death in diverse communities. 1,2 Despite extensive efforts focused on developing pharmacotherapies for treating substance use disorders, there is an urgent need for radically different therapeutic approaches. 3,4 Ibogaine provides an important drug prototype in this direction, as a psychoactive...

The dopaminergic alterations induced by 4‐F‐PCP and 4‐Keto‐PCP may enhance their drug‐induced rewarding and reinforcing effects: Implications for abuse

Addiction Biology July 1, 2021 Darlene Mae Ortiz, Raly James Perez Custodio, Arvie Abiero et al.

Abstract: Novel psychoactive substances remain the popular recreational drugs of use over the years. They continue to bypass government restrictions due to their synthesis and modifications. Recent additions to the lists are the 4‐F‐PCP and 4‐Keto‐PCP, analogs of the drug phencyclidine (PCP) known to induce adverse effects and abuse potential. However, studies on the abuse potential of 4‐F‐PCP...

Cannabis and synaptic reprogramming of the developing brain.

Nature Reviews Neuroscience July 2021 Anissa Bara, Jacqueline-Marie N Ferland, Gregory Rompala et al.

Recent years have been transformational in regard to the perception of the health risks and benefits of cannabis with increased acceptance of use. This has unintended neurodevelopmental implications given the increased use of cannabis and the potent levels of Δ9-tetrahydrocannabinol today being consumed by pregnant women, young mothers and teens. In this Review, we provide an overview of the...

Therapeutic potential of ketamine for alcohol use disorder.

Neuroscience & Biobehavioral Reviews July 1, 2021 Stephen D Worrell, Thomas J Gould 47 citations

Excessive alcohol consumption is involved in 1/10 of deaths of U.S. working-age adults and costs the country around $250,000,000 yearly. While Alcohol Use Disorder (AUD) pathology is complex and involves multiple neurotransmitter systems, changes in synaptic plasticity, hippocampal neurogenesis, and neural connectivity have been implicated in the behavioral characteristics of AUD. Depressed...

Pharmahuasca Reduces ROS Production and inflammatory Gene Expression in the Brain in a Model of PTSD: Exploration by RNA Sequencing

Research Square June 15, 2021 Dennis Parker Kelley, Katy Venable, Gerald Billac et al. 1 citation preprint

Abstract Post-traumatic stress disorder (PTSD) is associated with cognitive deficits, oxidative stress and inflammation. N,N-dimethyltryptamine (DMT) is a known neuroprotective, antioxidant, anti-inflammatory, and psychoplastogen with antidepressant effects. Therefore, we tested the capacity of DMT, the monoamine oxidase inhibitor (MAOI) harmaline, and “pharmahuasca” (DMT + harmaline) to reduce...

DOI: 10.21203/rs.3.rs-602961/v1 (opens in new tab) Full text (opens in new tab) Harmaline Oxidative stress Neuroprotection Pharmacology +5

Death risk: Lack of movement: The ignored pandemic of digitalization escalates the COVID-19 crisis

Technoetic Arts June 1, 2021 Lucas Pawlik

Data analysis from diverse medical fields suggests that we have reached a tipping point in the digitalization dynamic through the ongoing COVID-19 crisis, leading to an escalation of physical inactivity and related diseases. The lack of prioritization of physical activity designed to intervene against obesity, diabetes, loneliness, depression, anxiety disorders and suicide risk could...